| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 339225 | Psychosomatics | 2010 | 9 Pages |
Abstract
BackgroundOnly sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS.ObjectiveThe authors assessed and determined current treatment trends in AIDS psychiatry.MethodMembers of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey.ResultsOf 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam).ConclusionConsensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Oliver Freudenreich, Harold W. Goforth, Kelly L. Cozza, Matthew J. Mimiaga, Steven A. Safren, Grace Bachmann, Mary Ann. Cohen,